Furthermore, in this study, the authors demonstrate that miR-221 inhibition results in reduction of metastasis, increased apoptosis, reduced tumor growth, and inactivation of the NF-kB pathway, while the re-introduction of miR-221 leads to the gain of tumor properties. Here, NFKB1 is linked to neoplasm.